Rankings
Publications
Search Publications
Cited-By Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Login
Register
Home
Publications
Considerations in the Development of Stereoisomeric Drugs: FDA Viewpoint
Home
Publications
Considerations in the Development of Stereoisomeric Drugs: FDA Viewpoint
Considerations in the Development of Stereoisomeric Drugs: FDA Viewpoint
JW
Judi Weissinger
Judi Weissinger
Publisher Website
Google Scholar
Add to library
Cite
Download
Share
Download
1 October 1989
journal article
Published by
Springer Nature
in
Drug Information Journal
Vol. 23
(4)
,
663-667
https://doi.org/10.1177/009286158902300420
Abstract
No abstract available
Keywords
FDA VIEWPOINT
CONSIDERATIONS
DEVELOPMENT OF STEREOISOMERIC DRUGS
Cited by 12 articles